Our Research
Welcome to the Pergam Group. We study the prevention of infections in patients with cancer, transplant recipients and other immunocompromised populations, and investigate risk factors for healthcare and community-acquired infections in these groups. Dr. Steve Pergam actively leads development of new infection control strategies and educational programs as the Medical Director of Infection Control at Fred Hutch Cancer Center.
News
Dr. Steve Pergam receives Dr. Ali Al-Johani Award
Hutch News | Mary Engel | Feb. 7, 2018
The Dr. Ali Al-Johani Award recognizes exceptional medical care and compassion to transplant patients and families.
Flu season tips for cancer patients
Hutch News | Mary Engel | Feb. 6, 2018
Dr. Steve Pergam and other Fred Hutch infectious disease specialists offer tips on how immunocompromised patients can protect themselves from the flu, and to do if they get sick.
When bad bugs jump from farm to bedside
Hutch News | Mary Engel | Jan. 26, 2018
‘Big Chicken’ author, infectious disease researchers take aim at antibiotic resistance driven by agriculture, medicine.